Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease ; volume:5 ; number:02 ; year:2014 ; pages:171-174
Journal of neurosciences in rural practice ; 5, Heft 02 (2014), 171-174
- Contributor
-
Sankararaman, Senthilkumar
Riel-Romero, Rosario Maria
Jeroudi, Majed
Gonzalez-Toledo, Eduardo
- DOI
-
10.4103/0976-3147.131669
- URN
-
urn:nbn:de:101:1-2019111816125666912357
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sankararaman, Senthilkumar
- Riel-Romero, Rosario Maria
- Jeroudi, Majed
- Gonzalez-Toledo, Eduardo
Other Objects (12)
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
A case of Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis with severe cardiac complications
Hemophagocytic lymphohistiocytosis: pediatric hepatic perspective
Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
Chronic active Epstein–Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report
Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis
Chediak–Higashi Syndrome Presented With Hemophagocytic Lymphohistiocytosis
Acute polymyositis associated with hemophagocytic lymphohistiocytosis syndrome
Familial Hemophagocytic Lymphohistiocytosis Presenting as Hydrops Fetalis
Epidemiological investigation of hemophagocytic lymphohistiocytosis in China
Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
A case of Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis with severe cardiac complications
Hemophagocytic lymphohistiocytosis: pediatric hepatic perspective
Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
Chronic active Epstein–Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report
Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis
Chediak–Higashi Syndrome Presented With Hemophagocytic Lymphohistiocytosis
Acute polymyositis associated with hemophagocytic lymphohistiocytosis syndrome
Familial Hemophagocytic Lymphohistiocytosis Presenting as Hydrops Fetalis
Epidemiological investigation of hemophagocytic lymphohistiocytosis in China
Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
A case of Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis with severe cardiac complications
Hemophagocytic lymphohistiocytosis: pediatric hepatic perspective
Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
Chronic active Epstein–Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report
Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis
Chediak–Higashi Syndrome Presented With Hemophagocytic Lymphohistiocytosis
Acute polymyositis associated with hemophagocytic lymphohistiocytosis syndrome
Familial Hemophagocytic Lymphohistiocytosis Presenting as Hydrops Fetalis
Epidemiological investigation of hemophagocytic lymphohistiocytosis in China